Cargando…
Clinical practice and outcomes in advanced gastrointestinal stromal tumor: Experience from an Indian tertiary care center
BACKGROUND: Management of advanced Gastrointestinal stromal tumors (GIST) has been revolutionized with the use of Imatinib guided by mutation analysis. Data from India remains scarce. MATERIALS AND METHODS: Patients with metastatic GIST who were treated at Department of Gastro-intestinal & Hepat...
Autores principales: | Bose, Subhadeep, Ramaswamy, Anant, Sahu, Arvind, Shetty, Omshree, Zanwar, Saurabh S., Mirani, Jimmy, Nashikkar, Chaitali, Ostwal, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615878/ https://www.ncbi.nlm.nih.gov/pubmed/28975117 http://dx.doi.org/10.4103/sajc.sajc_323_16 |
Ejemplares similares
-
Unraveling the spectrum of KIT mutations in gastrointestinal stromal tumors: An Indian Tertiary Cancer Center Experience
por: Pai, Trupti, et al.
Publicado: (2017) -
Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers
por: Ramaswamy, Anant, et al.
Publicado: (2018) -
Pazopanib use preceding curative surgery in low rectal gastrointestinal stromal tumors after imatinib failure: A case report
por: Pande, Nikhil, et al.
Publicado: (2019) -
Calculation of a clinical predictive factors identifying peritoneal disease on a staging laparoscopy in gastric cancers
por: Harris, Caleb, et al.
Publicado: (2019) -
Experience with non-cremophor-based paclitaxel-gemcitabine regimen in advanced pancreatic cancer: Results from a single tertiary cancer centre
por: Ostwal, Vikas, et al.
Publicado: (2018)